ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
6Pounder
|
1 |
267 |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1
|
267
|
1
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Strategic Review Outcomes Investor Presentation
|
|
6Pounder
|
3 |
1.6K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
YOJ |
Re:
Ann: Board Changes
|
|
6Pounder
|
3 |
2.1K |
3 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
3
|
2.1K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Proposed issue of securities - NOV
|
|
6Pounder
|
44 |
11K |
7 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
44
|
11K
|
7
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
6Pounder
|
3 |
1.1K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Trading Halt
|
|
6Pounder
|
10 |
3.2K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
10
|
3.2K
|
3
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Managing Director Transition and CEO Recruitment
|
|
6Pounder
|
2 |
1.2K |
4 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
2
|
1.2K
|
4
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
6Pounder
|
6 |
1.8K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
6
|
1.8K
|
1
|
|
ASX - By Stock
|
TTT |
Re:
Ann: Settlement of Institutional Entitlement Offer
|
|
6Pounder
|
13 |
6.4K |
2 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
13
|
6.4K
|
2
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Q4 FY23 Market Update - Growth in FY23 of 99%
|
|
6Pounder
|
3 |
1.3K |
6 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
3
|
1.3K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
6Pounder
|
44 |
10K |
2 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
44
|
10K
|
2
|
|
ASX - By Stock
|
HIL |
Re:
Ann: Update on Legal Proceedings Quantum of Judgment
|
|
6Pounder
|
8 |
8.7K |
0 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
8
|
8.7K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Results of Entitlement Offer
|
|
6Pounder
|
14 |
3.4K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
14
|
3.4K
|
3
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Q3FY23 Update - March record trips and revenues
|
|
6Pounder
|
4 |
1.7K |
3 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
JAY |
Re:
News: JAY Jayride Group Says It Acquires Assets Of AirportShuttles.Com
|
|
6Pounder
|
1 |
411 |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
1
|
411
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
6Pounder
|
71 |
21K |
3 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
71
|
21K
|
3
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
6Pounder
|
3 |
1.2K |
1 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Q1 FY23 Update - Revenue up 157% vs PCP
|
|
6Pounder
|
1 |
730 |
5 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
1
|
730
|
5
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Q4 FY22 Market Update
|
|
6Pounder
|
5 |
1.7K |
1 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
5
|
1.7K
|
1
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Cash-Flow Positive after Stand-Still Op Costs for Q4 FY22
|
|
6Pounder
|
7 |
1.9K |
2 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Suspension from Official Quotation - AVEO
|
|
6Pounder
|
14 |
5.4K |
4 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
14
|
5.4K
|
4
|
|
ASX - By Stock
|
YOJ |
Re:
Ann: Quarterly Activities Report & Appendix 4C - Dec 2021
|
|
6Pounder
|
6 |
5.4K |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
6
|
5.4K
|
3
|
|
ASX - By Stock
|
TTT |
Re:
Ann: Titomic welcomes Repkon as $2.5m strategic investor
|
|
6Pounder
|
14 |
5.4K |
3 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
14
|
5.4K
|
3
|
|
ASX - By Stock
|
HUM |
Re:
I'm out. Can't afford the cost of opportunity anymore.
|
|
6Pounder
|
6 |
2.6K |
1 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
YOJ |
Re:
Ann: Quarterly Activity Report and App 4C Sep Q 2021
|
|
6Pounder
|
7 |
3.6K |
2 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
7
|
3.6K
|
2
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Global Travel Recovery Q1 FY22 Update
|
|
6Pounder
|
4 |
1.7K |
1 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
4
|
1.7K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase I clinical trial testing CBD product-enrolment begins
|
|
6Pounder
|
34 |
7.5K |
2 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
34
|
7.5K
|
2
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Response to ASX Price Query
|
|
6Pounder
|
145 |
17K |
3 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
145
|
17K
|
3
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
6Pounder
|
16 |
3.1K |
2 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
16
|
3.1K
|
2
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review Call Transcript
|
|
6Pounder
|
1 |
818 |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1
|
818
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
6Pounder
|
45 |
10K |
4 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
45
|
10K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for CBD human trial
|
|
6Pounder
|
61 |
16K |
4 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
61
|
16K
|
4
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Market Update
|
|
6Pounder
|
6 |
3.4K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
6
|
3.4K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Ann: HUM 1H21 announcement
|
|
6Pounder
|
195 |
73K |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
195
|
73K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Trading Halt
|
|
6Pounder
|
48 |
13K |
6 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
48
|
13K
|
6
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
6Pounder
|
33 |
5.1K |
0 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
33
|
5.1K
|
0
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Quarterly Business Review and Appendix 4C
|
|
6Pounder
|
6 |
2.8K |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
6
|
2.8K
|
1
|
|
ASX - By Stock
|
NOV |
Re:
Neobank Issues
|
|
6Pounder
|
16 |
4.2K |
4 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
16
|
4.2K
|
4
|
|
ASX - By Stock
|
KNM |
Re:
Ann: Enters Indian Education Sector with Licensing Agreement
|
|
6Pounder
|
41 |
7.5K |
2 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
41
|
7.5K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chairman's Address
|
|
6Pounder
|
35 |
10K |
3 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
BCT |
Re:
Ann: Appendix 4D and Half-Year Financial Report
|
|
6Pounder
|
18 |
40K |
0 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
18
|
40K
|
0
|
|
ASX - By Stock
|
JAY |
Re:
Ann: Transcript - FY20 Half-Year Results Presentation
|
|
6Pounder
|
11 |
9.4K |
2 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
11
|
9.4K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Appendix 4C - Quarterly
|
|
6Pounder
|
54 |
27K |
1 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
54
|
27K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Why invest in AVE
|
|
6Pounder
|
4 |
2.4K |
3 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
4
|
2.4K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Rights Issue - Appendix 3B
|
|
6Pounder
|
107 |
21K |
0 |
26/09/17 |
26/09/17 |
ASX - By Stock
|
107
|
21K
|
0
|
|